Oncology
🇪🇺 EMA Page 3EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 25–36 of 94 articles
Breast Cancer Insights: Key Abstracts for ESMO 2026
ESMO Updates Ovarian Cancer Guidelines: Key Changes and Implications
20 Must-Read Highlights from ESMO Breast Cancer Congress 2026
Biotheryx BTX-9341 Phase 1A Results to Be Presented at ESMO Breast Cancer Congress 2026
Heart Failure 2026: Vutrisiran Data & European Pharma News
Agenus Announces Q1 2026 Financial Report Date for Botensilimab and Balstilimab Cancer Programs
Oncolytics Biotech Reports Durable Responses with Pelareorep in RAS-Mutant Colorectal Cancer Trial
Nuvation Bio's IBTROZI Generates $18.5M Revenue in Q1 2026, Shows Strong First-Line Adoption in ROS1+ NSCLC
Swiss Biotech Day 2026: AI, Oncology, Microbiome Highlights
NICE Technology Appraisals: Impact on Market Access for Novel Oncology Drugs
CAR-T Cell Therapy Europe: Clinical Trials, Safety & Market Access Insights
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins as Strategic Adviser for DCVax Cancer Vaccine Development